查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372800

神經修復市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按類型、技術、按應用、地區和競爭細分

Neuroprosthetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Technique, By Application, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

神經修復市場在2022 年實現估值102.4 億美元，並預計在預測期內大幅成長，預計到2028 年年複合成長率為10.38%。神經修復市場目前正在經歷強勁擴張，受到以下多種因素的推動：從根本上重塑醫療保健和科技的交叉點。全球人口老化趨勢導致帕金森氏症、癲癇和脊髓損傷等神經系統疾病的盛行率增加，從而產生了對創新解決方案的巨大需求。尖端技術的進步，特別是在腦機介面（BCI）和神經植入領域，正在為神經假體的發展帶來前所未有的可能性。此外，政府和私人投資者的資金增加，加上支持性的監管框架，創造了有利於該領域研究和創新的環境。

患者對提高生活品質的期望提高、對客製化神經修復設備的渴望以及對可用選擇的認知增強，進一步推動了該市場的擴張。學術界、產業參與者和醫療機構的合作正在加速進展，而製造商之間的競爭則激勵著產品的不斷改進和成本的降低。除了醫療保健領域之外，神經修復市場在非醫療應用領域也展現了前景，涵蓋遊戲和輔助技術等領域，從而擴大了其範圍和影響力。

在這個充滿活力的商業環境中，處於神經假體研究和發展前沿的公司處於戰略地位，可以利用這些新興的機會。隨著市場的成熟和全球社會對神經假體解決方案的接受程度越來越高，能夠提供創新、有效且具有成本效益的設備的企業將在塑造醫療保健的未來以及人與機器之間的互動方面發揮關鍵作用。

市場概況
預測期 2024-2028
2022 年市場規模 102.4億美元
2028 年市場規模 185億美元
2023-2028 年年複合成長率 10.38%
成長最快的細分市場 脊髓刺激
最大的市場 北美洲

主要市場促進因素

神經系統疾病的發生率上升

神經系統疾病發生率的上升是神經修復市場蓬勃發展的關鍵驅動力。神經系統疾病涵蓋多種疾病，包括帕金森氏症、癲癇、脊髓損傷、阿茲海默症和中風等。幾個關鍵因素導致這些疾病的盛行率不斷增加，加劇了對神經假體解決方案的需求。

技術進步

技術進步處於推動神經修復市場快速成長的最前線。這些技術創新透過擴展神經義肢設備的可能性和功能，提高其有效性、安全性和可及性，正在徹底改變該領域。

最重要的技術突破之一是腦機介面（BCIs）的開發。腦機介面可以實現大腦和外部設備之間的直接通訊，使神經系統受損的人能夠控制義肢、電腦，甚至僅透過思想進行交流。微型化和改進的電極技術使腦機介面更加實用和方便用戶使用，為神經假體應用開闢了新的途徑。

神經植入物也受益於技術進步。這些植入神經系統的微型設備可以以更高的精確度和效率刺激或記錄神經活動。改良的材料、無線通訊和生物相容性塗層提高了神經植入物的壽命和功能，使其長期使用更加可靠。

此外，機器人技術和人工智慧（AI）的進步與神經修復學產生了協同作用。義肢現在配備了人工智慧驅動的演算法，可以實現自然和自適應的運動，從而提高截肢者的生活品質。人工智慧還可以幫助更準確地解碼神經訊號，增強對神經義肢設備的控制。

材料科學的創新促進了用於神經介面的軟性和生物相容性材料的開發，降低了組織損傷和排斥的風險。此外，3D 列印和奈米技術使得能夠根據個別患者的需求創建客製化的神經假體設備。

主要市場挑戰

生物相容性和安全性

生物相容性和安全性挑戰是神經假體市場最關心的問題之一。神經修復裝置通常直接與神經系統連接，必須與身體無縫整合，以避免不良反應並確保長期有效性。

一項主要挑戰是潛在的免疫反應和組織排斥。當異物或裝置被植入時，人體的免疫系統會將它們視為威脅並引發免疫反應。這可能會導致發炎、不適，嚴重時還會導致設備排斥。確保神經修復材料具有生物相容性並且不會引發免疫反應是一個關鍵障礙。

另一個安全問題涉及感染風險，特別是對於具有突破人體保護屏障的外部組件的設備。感染可能會損害設備的功能和患者的健康，因此需要仔細注意設備構造中使用的衛生和材料。

長期安全性和可靠性是重要的考慮因素。隨著時間的推移，材料的磨損、潛在的腐蝕或植入組件的分解可能會引起人們對設備功能和患者健康的擔憂。這需要持續監控、維護，在某些情況下還需要更換設備。

成本和可近性

成本和可近性挑戰是神經修復市場的重大障礙，限制了這些改變生活的技術向更廣泛的人群的普及。

首先，神經假體設備可能非常昂貴，包括研發、製造、外科手術和持續維護的成本。這種高昂的成本給醫療保健系統和個人帶來了沉重的負擔，通常使財力有限的人無法獲得這些先進的治療方法。

可訪問性是另一個關鍵問題。在許多地區，特別是在低收入國家或服務不足的社區，獲得醫療保健服務和專門的神經修復專業知識的機會有限。這種可近性的缺乏進一步加劇了醫療保健結果的差異，因為本來可以從神經修復干涉措施中受益的個人卻別無選擇。

主要市場趨勢

腦機介面 (BCI) 的進步

腦機介面 (BCI) 的進步代表了神經修復市場的變革趨勢。腦機介面是一種複雜的技術，可以實現人腦與外部設備之間的直接通訊，為患有神經系統疾病和殘疾的個人提供了重要的機會。

一項顯著的進步是非侵入性腦機介面的發展。這些系統通常依賴腦電圖（EEG），讓使用者只需透過思考即可控制設備或應用程式，而無需進行侵入性外科手術。非侵入式腦機介面正變得更加方便用戶使用、攜帶和易於使用，為輔助技術、遊戲和通訊等領域更廣泛的應用打開了大門。

侵入式腦機介面也取得了重大進展。這些設備涉及將電極直接植入大腦，以更高的精確度和解析度記錄或刺激神經活動。電極材料、植入技術和訊號處理的進步提高了侵入式腦機介面的壽命、可靠性和安全性。因此，人們正在探索它們的應用，例如恢復肢體功能、治療神經系統疾病，甚至增強認知能力。

此外，結合侵入性和非侵入性方法的混合腦機介面正在出現，在精確度和可訪問性之間提供平衡。這些混合系統旨在為使用者提供兩全其美的功能，以實現穩健的控制，同時最大限度地降低手術風險。

神經植入與神經調節

神經植入物和神經調節是神經修復市場不可或缺的組成部分，代表著旨在恢復或增強神經功能的強大技術。神經植入物通常採用小型裝置或電極的形式，旨在透過手術植入神經系統，從而與神經活動直接相互作用。這些植入物取得了重大進步，包括使用生物相容性材料、小型化和改進的電極設計，使它們更安全、更有效。

另一方面，神經調節涉及使用電或化學刺激來調節神經活動。深部腦部刺激 (DBS)、脊髓刺激 (SCS) 和迷走神經刺激 (VNS) 等技術用於治療各種神經系統疾病，例如巴金森氏症、慢性疼痛和癲癇。神經調節的進步包括開發更精確和適應性的刺激模式、可自訂的療法以及整合回饋機制以最佳化治療結果。

這些神經植入和神經調節的創新正在擴大神經系統疾病患者的治療選擇，為改善症狀管理、提高生活品質和減少對藥物的依賴提供了潛力。隨著研究和開發的繼續，神經修復市場預計這些技術的複雜性和適用性將進一步成長，以解決越來越多的神經系統疾病和病症。

細分市場洞察

類型洞察

輸入神經修復細分市場在神經修復市場中佔據主導地位，預計未來幾年將繼續擴大。首先，輸入神經修復部分主要包括腦機介面（BCI）和神經植入等技術，有助於將資訊或指令直接輸入神經系統。這些技術在恢復失去的感覺和運動功能方面具有巨大的前景，使其成為神經系統疾病或殘疾患者備受追捧的解決方案。

其次，輸入神經修復學的進步非常顯著。尤其是腦機介面，已經取得了重大突破，使得人腦和外部設備之間的通訊更加準確和高效。這開啟了多種應用，從針對行動障礙人士的輔助技術，到針對聽力或視力缺陷人士的感覺恢復。此外，神經系統疾病的日益流行，加上人口老化的不斷成長，對輸入神經修復術可以提供的解決方案產生了強勁的需求。隨著神經系統疾病持續影響全球數百萬人，對創新技術來提高生活品質的需求變得越來越明顯。此外，研究和開發投資以及學術機構和私營部門之間的合作加速了輸入神經修復術的開發和商業化。這推動了競爭，刺激了創新，並促進了市場成長。

區域洞察

由於多種因素的綜合作用，北美地區已成為 2022 年神經修復市場的領導者，使其成為神經修復創新和採用的蓬勃發展中心。首先，北美受益於由尖端研究機構、領先的醫療設施和創新技術公司組成的強大生態系統。這種協同作用培育了創新和協作的文化，促進了神經假體技術的快速進步。著名學術機構和研究中心的存在確保了突破性發現的源源不絕和訓練有素的人才庫。此外，北美強大的醫療基礎設施和高醫療支出水準為神經修復解決方案的開發和採用提供了有利的環境。完善的監管框架（例如美國 FDA 提供的監管框架）可確保神經義肢設備符合嚴格的安全性和有效性標準，從而增強患者和投資者的信心。該地區還擁有大量患有神經系統疾病和殘疾的患者，包括帕金森氏症、脊髓損傷和截肢等疾病。這群龐大的患者群推動了神經修復設備的市場需求。此外，北美神經修復治療的優惠報銷政策和保險範圍提高了可及性，使患者更容易獲得這些技術。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球神經假體市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（輸出神經修復和輸入神經修復）
    • 按技術（脊髓刺激、深部腦部刺激、迷走神經刺激和其他技術）
    • 按應用（帕金森氏症、阿茲海默症、癲癇、聽覺處理障礙、眼科疾病和其他應用）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美神經假體市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依技術
    • 按應用
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲神經修復術市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依技術
    • 按應用
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區神經修復市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依技術
    • 按應用
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲神經假體市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依技術
    • 按應用
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲神經修復市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 依技術
    • 按應用
    • 按國家/地區
  • MEA：國家分析
    • 南非神經修復術
    • 沙烏地阿拉伯神經修復術
    • 阿拉伯聯合大公國神經修復術

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購

第 13 章：全球神經修復市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代治療類型的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Medtronic PLC
    • LivaNova PLC
    • Demant A/S
    • MED-EL Corporation
    • Cochlear Limited
    • Abbott Laboratories
    • Boston Scientific Corp
    • Second Sight Medical Products, Inc.
    • Retina Implant AG
    • NeuroPace Inc

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 16258

The Neuroprosthetics Market achieved a valuation of USD 10.24 Billion in 2022 and is poised for substantial growth in the forecast period, with an anticipated CAGR of 10.38% through 2028. The Neuroprosthetics market is currently experiencing robust expansion, driven by a convergence of factors that are fundamentally reshaping the intersection of healthcare and technology. The global demographic trend toward an aging population has led to an increased prevalence of neurological disorders such as Parkinson's disease, epilepsy, and spinal cord injuries, thereby generating significant demand for innovative solutions. Cutting-edge technological advancements, particularly in the realm of brain-computer interfaces (BCIs) and neural implants, are unlocking unprecedented possibilities for the development of Neuroprosthetics. Furthermore, augmented funding from both governments and private investors, coupled with supportive regulatory frameworks, has fostered an environment conducive to research and innovation within this field.

Elevated patient expectations for an improved quality of life, the desire for customized Neuroprosthetics devices, and an enhanced awareness of available options are further fueling the expansion of this market. Collaborative efforts involving academia, industry players, and healthcare institutions are expediting progress, while competition among manufacturers is incentivizing continuous product enhancements and cost reductions. Beyond the realm of healthcare, the Neuroprosthetics market is demonstrating promise in non-medical applications, spanning areas such as gaming and assistive technology, thus broadening its scope and impact.

Within this dynamic business landscape, companies at the forefront of Neuroprosthetics research and development are strategically positioned to capitalize on these burgeoning opportunities. As the market matures and the global community becomes increasingly receptive to Neuroprosthetics solutions, businesses that can offer innovative, efficacious, and cost-effective devices are poised to play a pivotal role in shaping the future of healthcare and the interactions between humans and machines.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 10.24 Billion
Market Size 2028USD 18.50 Billion
CAGR 2023-202810.38%
Fastest Growing SegmentSpinal Cord Stimulation
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Neurological Disorders

The rising incidence of neurological disorders is a pivotal driver behind the burgeoning Neuroprosthetics market. Neurological disorders encompass a wide spectrum of conditions, including Parkinson's disease, epilepsy, spinal cord injuries, Alzheimer's disease, and stroke, among others. Several key factors contribute to the increasing prevalence of these disorders, thereby intensifying the demand for Neuroprosthetics solutions.

First and foremost, the global aging population plays a significant role in the escalating incidence of neurological disorders. As individuals age, their risk of developing conditions like Alzheimer's and Parkinson's disease increases, making these disorders more prevalent in older demographics. With an aging population in many parts of the world, the pool of potential Neuroprosthetics recipients expands.

Furthermore, lifestyle changes, environmental factors, and genetics also contribute to the rising incidence of neurological disorders. Sedentary lifestyles, unhealthy diets, and increased stress levels can contribute to conditions such as stroke and depression. Environmental factors like pollution and exposure to toxins can increase the risk of neurological diseases. Genetic predisposition can also be a significant factor in various neurological disorders.

The growing awareness and diagnosis of these conditions also contribute to the apparent increase in incidence. As medical knowledge and diagnostic tools advance, more individuals are being identified and treated for neurological disorders, further underscoring the need for Neuroprosthetics interventions.

Advancements in Technology

Advancements in technology are at the forefront of driving the rapid growth of the Neuroprosthetics market. These technological innovations are revolutionizing the field by expanding the possibilities and capabilities of Neuroprosthetics devices, enhancing their effectiveness, safety, and accessibility.

One of the most significant technological breakthroughs is in the development of brain-computer interfaces (BCIs). BCIs enable direct communication between the brain and external devices, allowing individuals with neurological impairments to control prosthetic limbs, computers, or even communicate through thought alone. Miniaturization and improved electrode technology have made BCIs more practical and user-friendly, opening new avenues for Neuroprosthetics applications.

Neural implants have also benefited from technological advancements. These tiny devices, implanted into the nervous system, can stimulate or record neural activity with increasing precision and efficiency. Improved materials, wireless communication, and biocompatible coatings have enhanced the longevity and functionality of neural implants, making them more reliable for long-term use.

Furthermore, advancements in robotics and artificial intelligence (AI) have synergized with Neuroprosthetics. Prosthetic limbs are now equipped with AI-driven algorithms that enable natural and adaptive movements, improving the quality of life for amputees. AI can also assist in decoding neural signals more accurately, enhancing the control of Neuroprosthetics devices.

Innovations in materials science have led to the development of flexible and biocompatible materials for neural interfaces, reducing the risk of tissue damage and rejection. Additionally, 3D printing, and nanotechnology have enabled the creation of customized Neuroprosthetics devices tailored to individual patient needs.

Key Market Challenges

Biocompatibility and Safety

Biocompatibility and safety challenges are among the foremost concerns in the Neuroprosthetics market. Neuroprosthetics devices, which often interface directly with the nervous system, must seamlessly integrate with the body to avoid adverse reactions and ensure long-term effectiveness.

One primary challenge is the potential for immune responses and tissue rejection. When foreign materials or devices are implanted, the body's immune system can perceive them as threats and mount immune responses. This can lead to inflammation, discomfort, and, in severe cases, the rejection of the device. Ensuring that Neuroprosthetics materials are biocompatible and do not trigger immune reactions is a critical hurdle.

Another safety concern relates to the risk of infection, especially for devices with external components that breach the body's protective barriers. Infections can compromise both the device's functionality and the patient's health, necessitating careful attention to hygiene and materials used in device construction.

Long-term safety and reliability are essential considerations. Over time, wear and tear on materials, potential corrosion, or the degradation of implanted components can raise concerns about device function and patient well-being. This requires continuous monitoring, maintenance, and, in some cases, device replacement.

Costs and Accessibility

Costs and accessibility challenges are significant barriers within the Neuroprosthetics market, limiting the reach of these life-changing technologies to a broader population.

Firstly, Neuroprosthetics devices can be prohibitively expensive, encompassing costs for research and development, manufacturing, surgical procedures, and ongoing maintenance. This high-cost places a substantial burden on healthcare systems and individuals, often making these advanced treatments inaccessible to those with limited financial resources.

Accessibility is another crucial issue. In many regions, especially in lower-income countries or underserved communities, access to healthcare services and specialized Neuroprosthetics expertise is limited. This lack of accessibility further exacerbates the disparities in healthcare outcomes, as individuals who could benefit from Neuroprosthetics interventions are left without options.

Key Market Trends

Advancements in Brain-Computer Interfaces (BCIs)

Advancements in Brain-Computer Interfaces (BCIs) represent a transformative trend within the Neuroprosthetics market. BCIs are sophisticated technologies that enable direct communication between the human brain and external devices, offering profound opportunities for individuals with neurological disorders and disabilities.

One notable advancement is the development of non-invasive BCIs. These systems, often relying on electroencephalography (EEG), allow users to control devices or applications simply by thinking, without the need for invasive surgical procedures. Non-invasive BCIs are becoming more user-friendly, portable, and accessible, opening the door to broader applications in fields like assistive technology, gaming, and communication.

Invasive BCIs have also seen significant progress. These devices involve implanting electrodes directly into the brain to record or stimulate neural activity with higher precision and resolution. Advancements in electrode materials, implantation techniques, and signal processing have improved the longevity, reliability, and safety of invasive BCIs. As a result, they are being explored for applications such as restoring limb function, treating neurological disorders, and even enhancing cognitive capabilities.

Furthermore, hybrid BCIs that combine both invasive and non-invasive approaches are emerging, offering a balance between precision and accessibility. These hybrid systems aim to provide users with the best of both worlds, allowing for robust control while minimizing surgical risks.

Neural Implants and Neuromodulation

Neural implants and neuromodulation are integral components of the Neuroprosthetics market, representing powerful technologies that aim to restore or enhance neurological function. Neural implants, often in the form of small devices or electrodes, are designed to be surgically implanted into the nervous system, allowing for direct interaction with neural activity. These implants have seen significant advancements, including the use of biocompatible materials, miniaturization, and improved electrode design, making them safer and more effective.

Neuromodulation, on the other hand, involves the use of electrical or chemical stimulation to modulate neural activity. Techniques like deep brain stimulation (DBS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS) are used to treat various neurological disorders such as Parkinson's disease, chronic pain, and epilepsy. Advancements in neuromodulation include the development of more precise and adaptive stimulation patterns, customizable therapies, and the integration of feedback mechanisms to optimize treatment outcomes.

These innovations in neural implants and neuromodulation are expanding treatment options for individuals with neurological conditions, offering the potential for improved symptom management, enhanced quality of life, and reduced reliance on medication. As research and development continue, the Neuroprosthetics market is expected to see further growth in the sophistication and applicability of these technologies, addressing an increasing range of neurological disorders and conditions.

Segmental Insights

Type Insights

The Input Neural Prosthetics Segment dominates the Neuroprosthetics market and is predicted to continue expanding over the coming years. Firstly, the Input Neural Prosthetics segment primarily encompasses technologies like Brain-Computer Interfaces (BCIs) and neural implants that facilitate the direct input of information or commands into the nervous system. These technologies hold immense promise in restoring lost sensory and motor functions, making them highly sought-after solutions for patients suffering from neurological disorders or disabilities.

Secondly, advancements in Input Neural Prosthetics have been remarkable. BCIs, in particular, have witnessed significant breakthroughs, enabling more accurate and efficient communication between the human brain and external devices. This has opened up diverse applications, from assistive technologies for individuals with mobility impairments to sensory restoration for those with hearing or vision deficits. Additionally, the increasing prevalence of neurological disorders, coupled with a growing aging population, has created a robust demand for solutions that Input Neural Prosthetics can provide. As neurological conditions continue to affect millions worldwide, the need for innovative technologies to enhance the quality of life becomes increasingly evident. Furthermore, research and development investments, as well as collaborations between academic institutions and the private sector, have accelerated the development and commercialization of Input Neural Prosthetics. This has driven competition, spurred innovation, and contributed to market growth.

Regional Insights

The North America region has established itself as the leader in the Neuroprosthetics Market in 2022 due to a combination of factors that make it a thriving hub for Neuroprosthetics innovation and adoption. First and foremost, North America benefits from a robust ecosystem of cutting-edge research institutions, leading medical facilities, and innovative technology companies. This synergy fosters a culture of innovation and collaboration, enabling rapid advancements in Neuroprosthetics technologies. The presence of renowned academic institutions and research centres ensures a steady flow of breakthrough discoveries and a well-trained talent pool. Moreover, North America's strong healthcare infrastructure and high healthcare expenditure levels provide a conducive environment for the development and adoption of Neuroprosthetics solutions. Well-established regulatory frameworks, such as those provided by the FDA in the United States, ensure that Neuroprosthetics devices meet rigorous safety and efficacy standards, instilling confidence in both patients and investors. The region also boasts a large patient population with neurological disorders and disabilities, including conditions like Parkinson's disease, spinal cord injuries, and limb amputations. This substantial patient base drives market demand for Neuroprosthetics devices. Furthermore, favourable reimbursement policies and insurance coverage for Neuroprosthetics treatments in North America enhance accessibility, making these technologies more attainable for patients.

Key Market Players

  • Medtronic PLC
  • LivaNova PLC
  • Demant A/S
  • MED-EL Corporation
  • Cochlear Limited
  • Abbott Laboratories
  • Boston Scientific Corp
  • Second Sight Medical Products, Inc.
  • Retina Implant AG
  • NeuroPace Inc

Report Scope:

In this report, the Neuroprosthetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neuroprosthetics Market, Type:

  • Output Neural Prosthetics
  • Input Neural Prosthetics

Neuroprosthetics Market, Technique:

  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Other Techniques

Neuroprosthetics Market, Application:

  • Parkinson's Disease
  • Alzheimer's Disease
  • Epilepsy
  • Auditory Processing Disorders
  • Ophthalmic Disorders
  • Other Applications

Neuroprosthetics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Neuroprosthetics Market.

Available Customizations:

  • Neuroprosthetics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Neuroprosthetics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Output Neural Prosthetics and Input Neural Prosthetics)
    • 5.2.2. By Technique (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, and Other Techniques)
    • 5.2.3. By Application (Parkinson's Disease, Alzheimer's Disease, Epilepsy, Auditory Processing Disorders, Ophthalmic Disorders, and Other Applications)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Neuroprosthetics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Neuroprosthetics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Neuroprosthetics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Neuroprosthetics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application

7. Europe Neuroprosthetics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Neuroprosthetics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
    • 7.3.2. United Kingdom Neuroprosthetics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
    • 7.3.3. Italy Neuroprosthetics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
    • 7.3.4. France Neuroprosthetics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Neuroprosthetics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Application

8. Asia-Pacific Neuroprosthetics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Neuroprosthetics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
    • 8.3.2. India Neuroprosthetics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Neuroprosthetics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Neuroprosthetics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Neuroprosthetics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application

9. South America Neuroprosthetics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Neuroprosthetics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Neuroprosthetics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Neuroprosthetics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application

10. Middle East and Africa Neuroprosthetics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Neuroprosthetics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Neuroprosthetics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Neuroprosthetics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions

13. Global Neuroprosthetics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Treatment Types

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Medtronic PLC
    • 15.5.2. LivaNova PLC
    • 15.5.3. Demant A/S
    • 15.5.4. MED-EL Corporation
    • 15.5.5. Cochlear Limited
    • 15.5.6. Abbott Laboratories
    • 15.5.7. Boston Scientific Corp
    • 15.5.8. Second Sight Medical Products, Inc.
    • 15.5.9. Retina Implant AG
    • 15.5.10. NeuroPace Inc

16. Strategic Recommendations

17. About Us & Disclaimer